Clinical Trials Browser

Phase 2 × 3-fluorobenzylguanidine × Clear all

NCT06858501 2025-12-31

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

Phase 2 Not yet recruiting

Ganglioneuroblastoma

NCT06233903 2025-01-21

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Phase 2 Withdrawn

Neuroblastoma, Paraganglioma, Pheochromocytoma